L. M. Villar

High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study

R. Toledano, J. Masjuán, A. Muriel, 2020, European Journal of Clinical Microbiology & Infectious Diseases.

Multiple sclerosis patients with anti‐lipid oligoclonal IgM show early favourable response to immunomodulatory treatment

J. Álvarez-cermeño, N. García-Barragán, P. Gónzalez-Porqué, 2009, European journal of neurology.

Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis

J. Gómez-Rial, J. Hillert, J. Álvarez-cermeño, 2008, Multiple sclerosis.

Influence of oligoclonal IgM specificity in multiple sclerosis disease course

J. Gómez-Rial, J. Álvarez-cermeño, E. Roldán, 2008, Multiple sclerosis.